SPRO
Spero Therapeutics, Inc.
+0.01 (+0.90%)1.12USD79.0K成交股數65.2M市值8.0本益比(近四季)5.2股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 63K |
| 近 180 天 淨額 | −63K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 | 08-06 | Zack Debra | Chief Medical Officer | A 獲配股票 | 162K | – | – | 162K | SEC |
| 2026-06-23 | 06-25 | Pottage John C Jr | Director | A 獲配股票 | 10.0K | – | – | 85.0K | SEC |
| 2026-06-23 | 06-25 | Jackson Scott Thomas | Director | A 獲配股票 | 10.0K | – | – | 85.0K | SEC |
| 2026-06-23 | 06-25 | THOMAS FRANK E | Director | A 獲配股票 | 10.0K | – | – | 85.0K | SEC |
| 2026-06-23 | 06-25 | Deshpande Milind | Director | A 獲配股票 | 10.0K | – | – | 101K | SEC |
| 2026-06-23 | 06-25 | Smith Cynthia | Director | A 獲配股票 | 10.0K | – | – | 85.0K | SEC |
| 2026-06-23 | 06-25 | Tregoning Kathleen | Director | A 獲配股票 | 10.0K | – | – | 85.0K | SEC |
| 2026-06-23 | 06-25 | VINK PATRICK V.J.J. | Director | A 獲配股票 | 10.0K | – | – | 85.0K | SEC |
| 2026-05-04 | 05-06 | Rajavelu Esther | See Remarks | S 公開市場賣出 | 25.2K | 2.51 | 63K | 987K | SEC |
| 2026-02-06 | 02-09 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 18.7K | 2.36 | 44K | 743K | SEC |
| 2026-02-06 | 02-09 | Rajavelu Esther | See Remarks | S 公開市場賣出 | 50.8K | 2.36 | 120K | 1.0M | SEC |
| 2026-02-06 | 02-09 | Rajavelu Esther | See Remarks | S 公開市場賣出 | 37.1K | 2.36 | 88K | 1.1M | SEC |
| 2026-02-04 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 3.5K | 2.24 | 8K | 761K | SEC |
| 2026-02-03 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 24.2K | 2.14 | 52K | 765K | SEC |
| 2026-02-02 | 02-05 | Keutzer Timothy | Chief Operating Officer | A 獲配股票 | 68.0K | – | – | 808K | SEC |
| 2026-02-02 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 18.9K | 2.20 | 42K | 789K | SEC |
| 2026-02-02 | 02-04 | Rajavelu Esther | See Remarks | A 獲配股票 | 249K | – | – | 1.1M | SEC |
| 2026-02-02 | 02-04 | Rajavelu Esther | See Remarks | S 公開市場賣出 | 18.4K | 2.20 | 41K | 1.1M | SEC |
| 2025-11-07 | 11-12 | Rajavelu Esther | See Remarks | S 公開市場賣出 | 40.3K | 2.37 | 95K | 869K | SEC |
| 2025-08-28 | 09-03 | Mahadevia Ankit | Director | S 公開市場賣出 | 6.6K | 1.97 | 13K | 703K | SEC |
| 2025-08-28 | 09-03 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 1.7K | 1.97 | 3K | 740K | SEC |
| 2025-06-12 | 06-16 | Smith Cynthia | Director | A 獲配股票 | 20.0K | – | – | 75.0K | SEC |
| 2025-06-12 | 06-16 | Mahadevia Ankit | Director | A 獲配股票 | 20.0K | – | – | 710K | SEC |
| 2025-06-12 | 06-16 | Tregoning Kathleen | Director | A 獲配股票 | 20.0K | – | – | 75.0K | SEC |
| 2025-06-12 | 06-16 | Jackson Scott Thomas | Director | A 獲配股票 | 20.0K | – | – | 75.0K | SEC |
| 2025-06-12 | 06-16 | VINK PATRICK V.J.J. | Director | A 獲配股票 | 20.0K | – | – | 75.0K | SEC |
| 2025-06-12 | 06-16 | Pottage John C Jr | Director | A 獲配股票 | 20.0K | – | – | 75.0K | SEC |
| 2025-06-12 | 06-16 | THOMAS FRANK E | Director | A 獲配股票 | 20.0K | – | – | 75.0K | SEC |
| 2025-06-12 | 06-16 | Deshpande Milind | Director | A 獲配股票 | 20.0K | – | – | 91.5K | SEC |
| 2025-05-02 | 05-06 | Rajavelu Esther | See Remarks | A 獲配股票 | 185K | – | – | 910K | SEC |
| 2025-02-05 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 27.6K | 0.78 | 22K | 766K | SEC |
| 2025-02-05 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 4.0K | 0.78 | 3K | 794K | SEC |
| 2025-02-05 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 24.9K | 0.78 | 19K | 741K | SEC |
| 2025-02-05 | 02-05 | Rajavelu Esther | CFO & CBO | S 公開市場賣出 | 20.7K | 0.78 | 16K | 725K | SEC |
| 2025-02-05 | 02-05 | Shukla Sath | CEO & President | S 公開市場賣出 | 106K | 0.78 | 83K | 1.7M | SEC |
| 2025-02-05 | 02-05 | Mahadevia Ankit | Director | S 公開市場賣出 | 14.0K | 0.78 | 11K | 745K | SEC |
| 2025-02-05 | 02-05 | Shukla Sath | CEO & President | S 公開市場賣出 | 42.8K | 0.78 | 33K | 1.8M | SEC |
| 2025-02-05 | 02-05 | Mahadevia Ankit | Director | S 公開市場賣出 | 55.3K | 0.78 | 43K | 690K | SEC |
| 2025-02-05 | 02-05 | Shukla Sath | CEO & President | S 公開市場賣出 | 6.1K | 0.78 | 5K | 1.9M | SEC |
| 2025-02-03 | 02-05 | Rajavelu Esther | CFO & CBO | A 獲配股票 | 266K | – | – | 645K | SEC |
| 2025-02-03 | 02-05 | Shukla Sath | CEO & President | A 獲配股票 | 751K | – | – | 1.9M | SEC |
| 2025-02-03 | 02-05 | Keutzer Timothy | Chief Operating Officer | A 獲配股票 | 266K | – | – | 798K | SEC |
| 2025-02-03 | 02-05 | Rajavelu Esther | CFO & CBO | A 獲配股票 | 100K | – | – | 745K | SEC |
| 2024-11-08 | 11-12 | Rajavelu Esther | CFO & CBO | S 公開市場賣出 | 17.2K | 1.30 | 22K | 379K | SEC |
| 2024-11-07 | 11-12 | Rajavelu Esther | CFO & CBO | S 公開市場賣出 | 23.4K | 1.31 | 31K | 397K | SEC |
| 2024-08-27 | 08-29 | Mahadevia Ankit | Director | S 公開市場賣出 | 5.9K | 1.35 | 8K | 759K | SEC |
| 2024-08-27 | 08-29 | Shukla Sath | CEO & President | S 公開市場賣出 | 2.8K | 1.35 | 4K | 1.1M | SEC |
| 2024-08-27 | 08-29 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 2.2K | 1.35 | 3K | 532K | SEC |
| 2024-08-05 | 08-06 | Shukla Sath | CEO and President | S 公開市場賣出 | 17.6K | 1.31 | 23K | 1.1M | SEC |
| 2024-08-02 | 08-06 | Shukla Sath | CEO and President | S 公開市場賣出 | 14.8K | 1.32 | 20K | 1.2M | SEC |
| 2024-05-29 | 05-30 | Pottage John C Jr | Director | A 獲配股票 | 20.0K | – | – | 55.0K | SEC |
| 2024-05-29 | 05-30 | THOMAS FRANK E | Director | A 獲配股票 | 20.0K | – | – | 55.0K | SEC |
| 2024-05-29 | 05-30 | Deshpande Milind | Director | A 獲配股票 | 20.0K | – | – | 71.5K | SEC |
| 2024-05-29 | 05-30 | Jackson Scott Thomas | Director | A 獲配股票 | 20.0K | – | – | 55.0K | SEC |
| 2024-05-29 | 05-30 | Mahadevia Ankit | Director | A 獲配股票 | 20.0K | – | – | 765K | SEC |
| 2024-05-29 | 05-30 | Tregoning Kathleen | Director | A 獲配股票 | 20.0K | – | – | 55.0K | SEC |
| 2024-05-29 | 05-30 | VINK PATRICK V.J.J. | Director | A 獲配股票 | 20.0K | – | – | 55.0K | SEC |
| 2024-05-29 | 05-30 | Smith Cynthia | Director | A 獲配股票 | 20.0K | – | – | 55.0K | SEC |
| 2024-02-05 | 02-05 | Shukla Sath | CEO and President | S 公開市場賣出(10b5-1) | 45.1K | 1.45 | 65K | 1.2M | SEC |
| 2024-02-02 | 02-05 | Shukla Sath | CEO and President | S 公開市場賣出(10b5-1) | 30.9K | 1.37 | 42K | 1.2M | SEC |
| 2024-02-02 | 02-05 | HAMED KAMAL | Chief Medical Officer | S 公開市場賣出 | 28.1K | 1.37 | 38K | 788K | SEC |
| 2024-02-02 | 02-05 | Keutzer Timothy | Chief Operating Officer | S 公開市場賣出 | 31.0K | 1.36 | 42K | 534K | SEC |
| 2024-02-02 | 02-05 | Mahadevia Ankit | Director | S 公開市場賣出 | 63.8K | 1.37 | 87K | 745K | SEC |
| 2024-02-02 | 02-05 | JOSEPH TAMARA L | Chief Legal Officer | S 公開市場賣出 | 30.9K | 1.37 | 42K | 532K | SEC |
| 2024-02-01 | 02-05 | HAMED KAMAL | Chief Medical Officer | A 獲配股票 | 240K | – | – | 816K | SEC |
| 2024-02-01 | 02-05 | Rajavelu Esther | See Remarks | A 獲配股票 | 120K | – | – | 420K | SEC |
| 2024-02-01 | 02-05 | Shukla Sath | CEO and President | A 獲配股票 | 680K | – | – | 1.3M | SEC |
| 2024-02-01 | 02-05 | Keutzer Timothy | Chief Operating Officer | A 獲配股票 | 240K | – | – | 565K | SEC |
| 2024-02-01 | 02-05 | JOSEPH TAMARA L | Chief Legal Officer | A 獲配股票 | 240K | – | – | 563K | SEC |
| 2023-11-13 | 11-15 | Rajavelu Esther | See Remarks | A 獲配股票 | 300K | – | – | 300K | SEC |
| 2023-10-05 | 10-10 | Mahadevia Ankit | Director | A 獲配股票 | 20.0K | – | – | 809K | SEC |
| 2023-10-05 | 10-10 | THOMAS FRANK E | Director | A 獲配股票 | 20.0K | – | – | 35.0K | SEC |
| 2023-10-05 | 10-10 | Smith Cynthia | Director | A 獲配股票 | 20.0K | – | – | 35.0K | SEC |
| 2023-10-05 | 10-10 | Tregoning Kathleen | Director | A 獲配股票 | 20.0K | – | – | 35.0K | SEC |
| 2023-10-05 | 10-10 | Deshpande Milind | Director | A 獲配股票 | 20.0K | – | – | 51.5K | SEC |
| 2023-10-05 | 10-10 | VINK PATRICK V.J.J. | Director | A 獲配股票 | 20.0K | – | – | 35.0K | SEC |
| 2023-10-05 | 10-10 | Jackson Scott Thomas | Director | A 獲配股票 | 20.0K | – | – | 35.0K | SEC |
| 2023-10-05 | 10-10 | Pottage John C Jr | Director | A 獲配股票 | 20.0K | – | – | 35.0K | SEC |
| 2023-09-13 | 09-15 | HAMED KAMAL | Chief Medical Officer | S 公開市場賣出 | 39.5K | 1.27 | 50K | 576K | SEC |
| 2023-08-29 | 08-30 | Shukla Sath | CEO and President | S 公開市場賣出(10b5-1) | 4.2K | 1.30 | 5K | 573K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| GSK plc | 9.2M | 20.3M | 新進 | 新進 |
| Pfizer Inc | 2.4M | 5.3M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 4.5M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 948K | 2.1M | 新進 | 新進 |
| Alphabet Inc. | 890K | 2.0M | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 759K | 1.7M | 新進 | 新進 |
| BlackRock, Inc. | 594K | 1.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 566K | 1.3M | 新進 | 新進 |
| RAYMOND JAMES FINANCIAL INC | 522K | 1.2M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 383K | 846K | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 333K | 736K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 288K | 636K | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 275K | 608K | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 257K | 568K | 新進 | 新進 |
| STATE STREET CORP | 215K | 475K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 158K | 349K | 新進 | 新進 |
| UBS Group AG | 140K | 309K | 新進 | 新進 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115K | 254K | 新進 | 新進 |
| NORTHERN TRUST CORP | 108K | 239K | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 104K | 231K | 新進 | 新進 |
| Ionic Capital Management LLC | 103K | 227K | 新進 | 新進 |
| Federation des caisses Desjardins du Quebec | 91.9K | 202K | 新進 | 新進 |
| Shay Capital LLC | 72.4K | 160K | 新進 | 新進 |
| Invesco Ltd. | 64.2K | 142K | 新進 | 新進 |
| SIMPLEX TRADING, LLC | 61.3K | 135K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 61 +11 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 61 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 21.5M · 36.9% |
| 合計季末市值 | 46.9M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 1.2M |
|---|---|
| 與上期比 | -16.3% |
| 佔流通股數 | 2.08% |
| 日均成交量 | 410K |
| 回補天數 | 3.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 1.2M | -16.3% | 2.08% | 410K | 3.0 |
| 2026-08-14 | 1.4M | -4.5% | 2.48% | 761K | 1.9 |
| 2026-07-31 | 1.5M | -28.4% | 2.60% | 2.5M | 1.0 |
| 2026-07-15 | 2.1M | -26.2% | 3.63% | 1.6M | 1.3 |
| 2026-06-30 | 2.9M | +56.4% | 4.92% | 2.8M | 1.0 |
| 2026-06-15 | 1.8M | +7.3% | 3.15% | 813K | 2.3 |
| 2026-05-29 | 1.7M | +3.6% | 2.93% | 869K | 2.0 |
| 2026-05-15 | 1.6M | +39.6% | 2.83% | 630K | 2.6 |
| 2026-04-30 | 1.2M | +59.9% | 2.03% | 385K | 3.1 |
| 2026-04-15 | 738K | +21.9% | 1.27% | 531K | 1.4 |
| 2026-03-31 | 605K | +12.6% | 1.04% | 326K | 1.9 |
| 2026-03-13 | 537K | -6.4% | 0.92% | 313K | 1.7 |
| 2026-02-27 | 574K | -19.8% | 0.99% | 271K | 2.1 |
| 2026-02-13 | 716K | -24.0% | 1.23% | 427K | 1.7 |
| 2026-01-30 | 942K | -9.4% | 1.62% | 235K | 4.0 |
| 2026-01-15 | 1.0M | +9.8% | 1.79% | 235K | 4.4 |
| 2025-12-31 | 947K | -10.3% | 1.63% | 246K | 3.9 |
| 2025-12-15 | 1.1M | +27.9% | 1.81% | 301K | 3.5 |
| 2025-11-28 | 826K | +34.1% | 1.42% | 386K | 2.1 |
| 2025-11-14 | 616K | +29.3% | 1.06% | 584K | 1.1 |
| 2025-10-31 | 476K | +50.8% | 0.82% | 1.6M | 1.0 |
| 2025-10-15 | 316K | -42.5% | 0.54% | 535K | 1.0 |
| 2025-09-30 | 549K | +19.8% | 0.94% | 266K | 2.1 |
| 2025-09-15 | 459K | -9.0% | 0.79% | 347K | 1.3 |
| 2025-08-29 | 504K | -45.6% | 0.87% | 372K | 1.4 |
| 2025-08-15 | 927K | -32.8% | 1.59% | 1.0M | 1.0 |